mci-196 has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadonosono, K; Muraoka, T; Ogihara, K; Terauchi, Y; Utsunomiya, H; Yamakawa, T | 1 |
| Fujita, M; Irie, J; Itoh, A; Itoh, H; Kato, M; Kawai, T; Kawano, Y; Kobayashi, N; Kusumoto, Y; Morimoto, K; Morinaga, R; Nakajima, Y; Sugizaki, T; Tagawa, H; Tanaka, K; Watanabe, M; Yamada, S | 1 |
2 other study(ies) available for mci-196 and Alloxan Diabetes
| Article | Year |
|---|---|
Colestimide improves glycemic control via hepatic glucose production in db/db mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Eating; Epichlorohydrin; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Resins, Synthetic | 2014 |
Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver.
Topics: Animals; Bile Acids and Salts; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fatty Liver; Female; Humans; Insulin Resistance; Liver; Liver X Receptors; Male; Mice; Mice, Inbred Strains; Middle Aged; Orphan Nuclear Receptors; Retrospective Studies; Triglycerides | 2015 |